HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Bladder Cancer

Bladder Cancer

Bladder cancer remains a significant focus of cancer research due to its prevalence and impact on public health. Studies delve into various aspects, from understanding its molecular mechanisms to exploring innovative treatment modalities. Researchers investigate genetic predispositions, environmental factors, and lifestyle influences contributing to its development. Advanced imaging techniques aid in early detection, enhancing prognosis and treatment outcomes. Immunotherapy, targeted therapies, and personalized medicine are promising avenues, aiming for improved efficacy and reduced side effects. Additionally, ongoing efforts emphasize the importance of patient education, early screening programs, and support networks. Collaborative endeavors between clinicians, scientists, and advocacy groups drive progress in bladder cancer research, ultimately aiming for better prevention, detection, and treatment strategies.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp